Chiasma, Inc. (CHMA) |
| 3.76 -0.24 (-6%) 04-24 15:47 |
| Open: | 4.08 |
| High: | 4.1 |
| Low: | 3.76 |
| Volume: | 8,196,718 |
| Market Cap: | 0(M) |
| PE Ratio: | -2.39 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 12.05 |
| Resistance 1: | 10.32 |
| Pivot price: | 10.30 |
| Support 1: | 10.29 |
| Support 2: | 10.27 |
| 52w High: | 5.74 |
| 52w Low: | 2.77 |
Chiasma, Inc. is a biopharmaceutical company in the advanced stages of clinical development, specializing in oral drug formulations. The company utilizes its Transient Permeability Enhancer (TPE) technology platform to develop treatments for rare and serious chronic conditions on a global scale. A key product in its pipeline is MYCAPSSA, an oral octreotide capsule currently in Phase III clinical trials. MYCAPSSA is intended for adult patients diagnosed with acromegaly, a disorder marked by the overproduction of growth hormone in the body. Founded in 2001, Chiasma, Inc. is headquartered in Needham, Massachusetts.
| EPS | 0.000 |
| Book Value | -0.410 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Thu, 10 Nov 2022
Lj Skye Trustees Ltd. Net Worth (2026) - GuruFocus
Tue, 12 Jul 2022
SpyBiotech Appoints Mark Leuchtenberger as Chief Executive Officer - citybiz
Wed, 05 May 2021
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases - GlobeNewswire
Mon, 11 Apr 2016
Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept Pharmaceuticals (NASDAQ:ICPT) Gilead Sciences, Inc (NASDAQ:GILD) Clovis Oncology, Inc. (NASDAQ:CLVS) Chiasma, Inc. (NASDAQ:CHMA) - marketexclusive.com
Fri, 28 Aug 2026
Fri, 28 Aug 2026
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |